CARM1 and glioblastoma: In summary, PRMT3 and CARM1 are viewed as potential oncogenes, their overexpression significantly impacting a variety of cancers (as shown in Figure 3), such as colorectal, liver, pancreatic, prostate, endometrial, breast, [63] ovarian, oral cancers, and glioblastomas(as shown in Table 1).